Malignant Biliary Tract Neoplasm — Trials

Malignant Biliary Tract Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,281 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 366
Recruiting: 208
Ph III recruiting: 19
Growth YoY: +14.8%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (152)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05510427	Phase Ib Trial of Infigratinib In Combination With Atezolizumab And Bevacizumab for The Second-Line Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion/Amplification	withdrawn	Phase 1	0	M.D. Anderson Cancer CenterOTHER	0	Aug 15, 2023	clinicaltrials
NCT04480190	Neoadjuvant Therapy in Biliary Adenocarcinoma	withdrawn	Phase 1	0	Jordan KharofaOTHER	1	Apr 20, 2022	clinicaltrials